임상 한눈에 보기

• 3건의 ClinicalTrials.gov 임상 기록
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• Phase: Phase 3 · Phase 1, Phase 2
• Status: Completed
• 주요 endpoint: Incidence of adverse events (AEs) · Incidence and severity of adverse events Grade >/= 3 · according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) · Version 4.0 · Incidence of cardiac events (composite outcome measure): congestive heart failure (CHF) and cardiac death
• 등록 대상자(표본 합산): 약 793명
• 등록된 결과: ORR 7.1%
• 핵심: This Phase Ib-IIa, multi-institutional, open-label, dose-escalation study is designed to evaluate the safety, tolerabili…

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.